Boston Scientific on Pace for Largest Percent Decrease Since April -- Data Talk

Dow Jones01-15

Boston Scientific Corporation $(BSX)$ is currently at $90.02, down $3.72 or 3.97%

 

--Would be lowest close since April 4, 2025, when it closed at $89.70

--On pace for largest percent decrease since April 10, 2025, when it fell 4.27%

--Currently down six consecutive days; down 8.75% over this period

--Longest losing streak since Dec. 9, 2025, when it fell for seven straight trading days

--Worst six-day stretch since the six days ending Sept. 17, 2025, when it fell 8.87%

--Down 5.59% month-to-date

--Down 5.59% year-to-date

--Down 16.76% from its all-time closing high of $108.14 on Sept. 8, 2025

--Down 8.30% from 52 weeks ago (Jan. 16, 2025), when it closed at $98.17

--Down 16.76% from its 52-week closing high of $108.14 on Sept. 8, 2025

--Up 0.36% from its 52-week closing low of $89.70 on April 4, 2025

--Traded as low as $87.22; lowest intraday level since April 9, 2025, when it hit $86.77

--Down 6.96% at today's intraday low; largest intraday percent decrease since Oct. 1, 2025, when it fell as much as 7.11%

--Third worst performer in the S&P 500 today

--Ninth most active stock in the S&P 500 today

 

All data as of 10:52:54 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

January 15, 2026 10:55 ET (15:55 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment